FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Clears New Version of UroViu Endoscope

FDA clears a UroViu 510(k) for its UV5000 cordless, single-use endoscope platform.

latest-news-card-1
Human Drugs

No IND Submitted for Study

FDA warns San Francisco, CA-based dentist Pamela Den Besten about conducting a clinical trial on an investigational drug without an IND in place.

Human Drugs

Multiple Violations at Persōn & Covey

FDA warns Glendale, CA-based Persōn & Covey about CGMP violations in its production of unapproved drugs.

latest-news-card-1
Human Drugs

CDER Head Targets Surrogate Endpoints, Lupus Drug

In an unprecedented LinkedIn post, CDER director George Tidmarsh questions the use of surrogate endpoints and publicly attacks Aurinia Pharmas Lupus d...

latest-news-card-1
Human Drugs

Quantitative Medicine CoE Progress Update

The CDER Quantitative Medicine Center of Excellence issues a report on goals and accomplishments in the first 16 months of its existence.

FDA General

Sharp Reductions in FDA Operations Under Shutdown: HHS

An HHS contingency plan says FDA would experience sharp reductions in operations if Congress fails to reach a deal to fund the government.

latest-news-card-1
Medical Devices

FDA Approves New Zoll Monitor/Defibrillator

FDA approves a Zoll Medical PMA for Zenix, the companys newest monitor/defibrillator, which the company says is designed to streamline emergency and h...

latest-news-card-1
Human Drugs

OND Custom Medical Queries Are Useful: Article

FDA researchers say the OND Custom Medical Queries developed to improve the identification and analysis of new drug safety signals have improved FDAs ...

latest-news-card-1
Human Drugs

New Guidance on Adaptive Clinical Trial Designs

FDA posts an International Council for Harmonization draft guideline entitled E20 Adaptive Designs for Clinical Trials that provides recommendations o...

latest-news-card-1
Medical Devices

CDRH Expands Recall of BD Alaris Pump Infusion Sets

FDA issues an updated alert about an ongoing Class 1 recall of certain BD Alaris Pump Module infusion sets due to device performance issues.